(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...
(RTTNews) - Sagent Pharmaceuticals has recalled two lots of chemotherapy drug Docetaxel Injection, USP due to potential presence of particulate matter from the stopper in the drug, according to the ...
April 19, 2012 — Hospira Inc has initiated a voluntary recall of morphine sulfate injections because of a customer report of 2 Carpuject syringes containing more than the 1 mL labeled fill volume. The ...
Credit: FDA. The issue is related to an incomplete crimp seal that may cause the product to leak. At this time, there have been no reports of adverse events related to this recall. Hospira is ...
Hospira has notified healthcare professionals of a recall of one lot of Hydromorphone HCl Injection 1mg/mL due to reports of a single Carpuject containing more than the 1mL labeled fill volume. Opioid ...
On May 18, 2012, Hospira issued a safety alert to healthcare professionals about potential, clinically significant volume overfill in prefilled Carpuject and iSecure syringe systems—more than twice ...
UNDATED - Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...
One lot of hydromorphone HCI injection 1 mg/mL manufactured by Hospira (Dilaudid) is being recalled due to reports that the prefilled glass cartridges designed for use in the Carpuject Syringe system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results